Natco Pharma Limited — MF Holdings India

Pharmaceuticals & Biotechnology

Natco Pharma Limited

ISIN: INE987B01026 · Data as of Apr 2026

Share: WhatsApp X

Active Funds Holding

vs Last Month

+2 funds

Total Value

₹245.27 Cr

Avg Weight

1.2%

New Entries

Exits

Top Holder

Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct Plan - Growth 1.89%

ℹ️ Index funds and ETFs are excluded from this analysis. They passively track an index and hold stocks mechanically — not because of a fund manager's conviction. Only actively managed funds reflect genuine fund manager decisions.

📋 What Changed This Month

Natco Pharma Limited is currently held by 14 active mutual funds (excluding ETFs and Index funds) with a total exposure of ₹245.27 Cr. This month 2 funds entered. Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct Plan - Growth has the highest allocation at 1.89%, followed by Sundaram Long Term Micro Cap Tax Advantage Fund Series IV Direct Plan - Growth at 1.87%. ↓ Scroll down for full fund list and monthly changes.

Trend

Active Fund Count — Last 3 Months

Feb

Mar

Apr

This Month

Portfolio Changes — Apr 2026

▲ New Entries (2)

JioBlackRock Flexi Cap Fund - Direct Plan - Growth Option 0.53%

BANDHAN MULTI CAP FUND - GROWTH - DIRECT PLAN 0.26%

↑ Increased (3)

Tata Value Fund -Direct Plan Growth Option +0.03%

ITI Business Cycle Fund- Direct Plan- Growth +0.01%

Franklin India Multi-Factor Fund- Direct- Growth +0.04%

↓ Decreased (9)

Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct Plan - Growth -0.1%

Sundaram Long Term Micro Cap Tax Advantage Fund Series IV Direct Plan - Growth -0.09%

Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Direct Plan - Growth -0.1%

Sundaram Long Term Micro Cap Tax Advantage Fund Series V Direct Plan - Growth -0.1%

Sundaram Long Term Tax Advantage Fund Series III Direct Plan - Growth -0.08%

Sundaram Long Term Tax Advantage Fund Series IV Direct Plan - Growth -0.08%

Sundaram Small Cap Fund Direct Plan - Growth -0.21%

Tata Small Cap Fund-Direct Plan-Growth -0.03%

By Category

Fund Category Breakdown

Category	Funds	Avg Weight
Equity	9	1.41%
Small Cap	3	1.21%
Multi Cap	1	0.26%
Value/Contra	1	1.05%
Flexi Cap	1	0.53%

All Holdings

All 14 Active Funds Holding Natco Pharma Limited

Filter:

Fund ↕	Category ↕	Weight ↕	Value ↕	Change ↕
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct Plan - Growth Sundaram Mutual Fund	Equity	1.89%	₹1.42 Cr	-0.1%
Sundaram Long Term Micro Cap Tax Advantage Fund Series IV Direct Plan - Growth Sundaram Mutual Fund	Equity	1.87%	₹66.94 L	-0.09%
Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Direct Plan - Growth Sundaram Mutual Fund	Equity	1.85%	₹67.74 L	-0.1%
Sundaram Long Term Micro Cap Tax Advantage Fund Series V Direct Plan - Growth Sundaram Mutual Fund	Equity	1.84%	₹56.31 L	-0.1%
Sundaram Long Term Tax Advantage Fund Series III Direct Plan - Growth Sundaram Mutual Fund	Equity	1.83%	₹62.19 L	-0.08%
Sundaram Long Term Tax Advantage Fund Series IV Direct Plan - Growth Sundaram Mutual Fund	Equity	1.81%	₹41.06 L	-0.08%
Sundaram Small Cap Fund Direct Plan - Growth Sundaram Mutual Fund	Small Cap	1.76%	₹62.81 Cr	-0.21%
Tata Value Fund -Direct Plan Growth Option Tata Mutual Fund	Value/Contra	1.05%	₹90.40 Cr	+0.03%
ITI Business Cycle Fund- Direct Plan- Growth ITI Mutual Fund	Equity	1.01%	₹1.04 Cr	+0.01%
Tata Small Cap Fund-Direct Plan-Growth Tata Mutual Fund	Small Cap	0.53%	₹60.16 Cr	-0.03%
JioBlackRock Flexi Cap Fund - Direct Plan - Growth Option JioBlackRock Mutual Fund	Flexi Cap	0.53%	₹16.20 Cr	NEW
Franklin India Multi-Factor Fund- Direct- Growth Franklin Templeton Mutual Fund	Equity	0.50%	₹2.69 Cr	+0.04%
BANDHAN MULTI CAP FUND - GROWTH - DIRECT PLAN Bandhan Mutual Fund	Multi Cap	0.26%	₹7.51 Cr	NEW
JioBlackRock Sector Rotation Fund - Direct Plan - Growth Option JioBlackRock Mutual Fund	Equity	0.06%	₹9.08 L	-0.01%